TVM Capital Life Science is a transatlantic Venture Capital firm with teams in North America and Europe, focused on breakthrough therapies and medical products. They invest in early-stage therapeutics and differentiated commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics.
Access investment thesis, focus areas, bio, and contact details for Catello Somma and 22,000+ other VC professionals.